Atrial fibrillation patients do not benefit from acetylsalicylic acid

Conclusion Acetylsalicylic acid as monotherapy in stroke prevention of atrial fibrillation has no discernable protective effect against stroke, and may even increase the risk of ischaemic stroke in elderly patients. Thus, our data support the new European guidelines recommendation that ASA as monotherapy should not be used as stroke prevention in atrial fibrillation.
Source: Europace - Category: Cardiology Authors: Tags: Atrial fibrillation Source Type: research